154 related articles for article (PubMed ID: 34109610)
1. Are treatment response assessment maps (TRAMs) and
Kowa JY; Millard T; Goldman A; Sharma RK; Attygalle A; Mahalingam P; Marshall K; Welsh L; Li S; Mackinnon A; Rich P; Nicholson E; Iyengar S; El-Sharkawi D; Chau I; Cunningham D; Sharma B
Br J Haematol; 2021 Oct; 195(1):e116-e119. PubMed ID: 34109610
[No Abstract] [Full Text] [Related]
2. Primary Central Nervous System Natural Killer Cell Lymphoma in a Chinese Woman with Atypical (11)C-Choline Positron Emission Tomography and Magnetic Resonance Spectrometry Findings.
Li LF; Taw BB; Pu JK; Hwang GY; Lui WM; Leung GK
World Neurosurg; 2015 Oct; 84(4):1176.e5-9. PubMed ID: 26142813
[TBL] [Abstract][Full Text] [Related]
3. Use of F-18 FDG PET/CT in non-Hodgkin lymphoma with central nervous system involvement.
Cimarelli S; Sebban C; Thiesse P; Sunyach MP; Blay JY; Ghesquières H
Clin Nucl Med; 2011 Jun; 36(6):e45-9. PubMed ID: 21552016
[TBL] [Abstract][Full Text] [Related]
4. A vascular lesion mimicking a primitive brain tumour in a patient examined by (18)F-choline PET/CT and MRI.
Cascini GL; Restuccia A; De Vincenti T; Manti F; Calabria F
Rev Esp Med Nucl Imagen Mol; 2015; 34(5):335-6. PubMed ID: 25840881
[No Abstract] [Full Text] [Related]
5. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
6. Can metabolic tumor parameters on primary staging
Okuyucu K; Alagoz E; Ince S; Ozaydin S; Arslan N
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(1):9-14. PubMed ID: 28733137
[TBL] [Abstract][Full Text] [Related]
7.
Zhou W; Wen J; Hua F; Xu W; Lu X; Yin B; Geng D; Guan Y
Eur J Radiol; 2018 Jul; 104():26-32. PubMed ID: 29857862
[TBL] [Abstract][Full Text] [Related]
8. Follicular lymphoma transforming into diffuse large B-cell lymphoma in spleen: Simultaneous appearance of both on
Makis W; Ciarallo A; Petrogiannis-Haliotis T; Rosenberg A; Probst S
Clin Imaging; 2017; 43():88-92. PubMed ID: 28259031
[TBL] [Abstract][Full Text] [Related]
9. Neurolymphomatosis on 18F-FDG PET/CT: Diagnosis and Therapy Response.
Gykiere P; Jans L; Degrieck B; Goethals I
Clin Nucl Med; 2016 Feb; 41(2):142-3. PubMed ID: 26402124
[TBL] [Abstract][Full Text] [Related]
10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
11. 18F-Choline and 18F-FDG PET/CT in a Patient With Diffuse Large B-Cell Lymphoma and Recurrent Prostate Cancer.
De Leiris N; Riou L; Leenhardt J; Vuillez JP; Djaileb L
Clin Nucl Med; 2018 Dec; 43(12):e471-e472. PubMed ID: 30300202
[TBL] [Abstract][Full Text] [Related]
12. Comparison of PET/MRI With PET/CT in the Evaluation of Disease Status in Lymphoma.
Afaq A; Fraioli F; Sidhu H; Wan S; Punwani S; Chen SH; Akin O; Linch D; Ardeshna K; Lambert J; Miles K; Groves A; Kayani I
Clin Nucl Med; 2017 Jan; 42(1):e1-e7. PubMed ID: 27607161
[TBL] [Abstract][Full Text] [Related]
13. [
Hovhannisyan N; Fillesoye F; Guillouet S; Ibazizene M; Toutain J; Gourand F; Valable S; Plancoulaine B; Barré L
Theranostics; 2018; 8(16):4563-4573. PubMed ID: 30214639
[TBL] [Abstract][Full Text] [Related]
14. Diffuse Large B-Cell Lymphoma in the Era of Precision Oncology: How Imaging Is Helpful.
Shah HJ; Keraliya AR; Jagannathan JP; Tirumani SH; Lele VR; DiPiro PJ
Korean J Radiol; 2017; 18(1):54-70. PubMed ID: 28096718
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of using 18F-FDG PET and PET/CT in immunocompetent patients with primary central nervous system lymphoma: A systematic review and meta-analysis.
Zou Y; Tong J; Leng H; Jiang J; Pan M; Chen Z
Oncotarget; 2017 Jun; 8(25):41518-41528. PubMed ID: 28514747
[TBL] [Abstract][Full Text] [Related]
16. Differential Diagnosis of Sinonasal Lymphoma and Squamous Cell Carcinoma on CT, MRI, and PET/CT.
Kim SH; Mun SJ; Kim HJ; Kim SL; Kim SD; Cho KS
Otolaryngol Head Neck Surg; 2018 Sep; 159(3):494-500. PubMed ID: 29661053
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of interleukin-10 in cerebrospinal fluid for diffuse large B-cell lymphoma of the central nervous system.
Sasagawa Y; Akai T; Tachibana O; Iizuka H
J Neurooncol; 2015 Jan; 121(1):177-83. PubMed ID: 25258254
[TBL] [Abstract][Full Text] [Related]
18. Recurrent lymphoma in the thyroid gland detected by fluorine-18-fluorodeoxyglucose PET/CT.
Treglia G; Del Ciello A; Di Franco D
Endocrine; 2013 Feb; 43(1):242-3. PubMed ID: 22948774
[No Abstract] [Full Text] [Related]
19. [¹⁸F]FDG-positron emission tomography coregistration with computed tomography scans for radiation treatment planning of lymphoma and hematologic malignancies.
Terezakis SA; Hunt MA; Kowalski A; McCann P; Schmidtlein CR; Reiner A; Gönen M; Kirov AS; Gonzales AM; Schöder H; Yahalom J
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):615-22. PubMed ID: 20933343
[TBL] [Abstract][Full Text] [Related]
20. Fluorine-18 fluorodeoxyglucose PET-CT for extranodal staging of non-Hodgkin and Hodgkin lymphoma.
Ömür Ö; Baran Y; Oral A; Ceylan Y
Diagn Interv Radiol; 2014; 20(2):185-92. PubMed ID: 24412817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
